Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosign Technologies Inc BITKF

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.


GREY:BITKF - Post by User

Bullboard Posts
Post by Tigers21on Nov 22, 2005 1:54am
155 Views
Post# 9897921

So if allburg is getting a royalty now...?

So if allburg is getting a royalty now...?When do we as shareholders get a dividend? And has Rieveley calculated the impact of a 25 percent drag from the skim of 25 percent of gross profits by allburg...into his break even calculations re number of units needed to be sold .tablets needed to be sold....that is shown on the bio. website...etc.... What has Allburg contributed to warrant the $17,000 approx take from the profits...even before biotech breaks even....given RR 's statement of his intended...way or raising cash until such time as biotech holdings becomes self sustaining? Is this information provided in the wake of the tsx compliance review...re the $17,165 dollars already apparently coming to Allburg...in the way of royalties correct?....What is RR going to do to restore the balance to the rest of the shareholders...given his method of raising cash...somehow both the 25 percent skim from the gross profit based on 100 percent of the gross profit...???..as a royalty going to Allburg..in conjunction with the RR method of raising money...and the PP's...etc..seems a tad top heavy....So where is the balance for the shareholders...HOpefully this will be clarified...and the tsx can reconfirm if that $17,165 figure even before bio reaches break even is correct ?....We will just have to see how the tsx views all of this together..I quess.....Bio is not dull...that is for sure.
Bullboard Posts